Zagazig University Faculty of Human Medicine
Zagazig, 44519, Egypt
NCT Number: NCT04615702
This study aims to assess the outcome of standardized evidence-based care to all patients with acute biliary pancreatitis treated at surgery department, Zagazig University hospitals during the period from may, 2017 to may 2019.
Looking for future studies?
Notify MeAll sexes
Observational
Zagazig, 44519, Egypt
Acute pancreatitis (AP) is one of the most important gastrointestinal disorders causing emotional and physical human burden . The annual incidence worldwide for AP is 4.9-73.4 cases per 100,000 people and the overall mortality rate is 4 to 8%, which increases to 33% in patients with infected necrosis. AP is diagnosed when two of three criteria are fulfilled: typical abdominal pain of AP, more than three times elevated serum amylase/lipase level and signs of AP on imaging.
It is necessary to clarify the etiology of AP promptly. The diagnosis of gallstones, as the leading cause for AP, should have the top priority as that will direct the treatment policy. Long standing alcohol consumption and gallstones disease incriminated in the majority of cases with AP. Small common bile duct stones, in particular, are the cause of AP in approximately 32 to 40% of cases. In 10-30% of cases, the cause is unknown, so studies have suggested that up to 70% of cases of idiopathic pancreatitis are secondary to biliary microlithiasis.
The pathogenesis of biliary AP has been intensively investigated. Many theories explain how gallstones can trigger AP. The predominant theories include common pathway theory and gallstone migration theory. In general, AP occurs when intracellular protective mechanisms fail to prevent trypsinogen activation or reduce trypsin activity.
It is important that management of such potentially life threatening condition to be guided by an evidence-based approach. After comparing the Japanese (JPN) Guidelines 2015 and its former edition 2010 with the other two guidelines, International Association of Pancreatology/American Pancreas Association guidelines (IAP/APA), 2013 and American College of Gastroenterology (ACG), 2013, the JPN Guidelines, 2015 proved to be the highest quality regarding its systematic literature review prepared by the meta-analysis team, including the grading of recommendations and providing pancreatitis bundles.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Laboratory ( elevated serum lipase or amylase at least 3 times above the normal limits) is helpful in diagnosis
Acute pancreatitis is diagnosed when two of three criteria are present including:
helpful in diagnosis of acute pancreatitis and its etiology (Gallstones)
helpful in diagnosis of acute pancreatitis and its etiology . assist in detection of type and severity of acute pancreatitis
help in diagnosis of the etiology of acute pancreatitis elevated Bilirubin, ALT, AST and alkaline phosphatase suggest biliary pancreatitis
helpful in idiopathic acute pancreatitis diagnosis
The initial infusion rate for mild cases :
The initial infusion rate for both severe cases :
Other names: hartmann's solution
Pain control (Modified World Health organization (WHO) analgesia ladder) Step1: NSAID / paracetamol Paracetamol 1gm IV infusion /8h + Diclofenac sodium 75mg /12h.
Step 2: Opiates +/- NSAID/ paracetamol Pethidine 25 mg IV/4h
Step 3: Interventional treatment (epidural analgesia) +/- opiates +/- NSAID/ paracetamol In case of severe pain not responding to the above analgesia
Other names: NSAID (Diclofenac sodium) paracetamol (perfalgan drip) Opiates (Pethidine)
b. Therapeutic (in cases with pancreatic or extrapancreatic infections)
Other names: Quinolones (ciprofloxacin) Metronidazole (flagyl) Carbapenems (Imipenem)
Severe cases Timing: Within at least 48 hrs of admission provided that there are no intestinal complications.
Route: Nasogastric tube Nutrients: Polymeric feeding formula
Other names: polymeric feeding formula
in case of ileus or vomiting
Open necrosectomy was done after failure of the minimally invasive techniques. The procedure was done under general anesthesia under the coverage of Tienam (.5gm/6h IV) following the results of culture and sensitivity of the percutaneous drain effluent Surgical exploration of the peritoneal cavity was done through midline exploratory incision, there were 2 large pus collections extending from the Rt. and Lt. Lumber regions deep down into the pelvis, the intervening septa were divided and the pus was aspirated by a wide suction drain.
The lesser sac was opened and necrosectomy was done The previously placed PCD repositioned in the site of necrosectomy as a port for continuous irrigation while a wide tube drain was placed in the lesser sac for drainage. Another 2 tube drains were placed in the pelvis.
for pancreatic pseudocyst Antibiotic prophylaxis with Ciprofloxacin 400mg IV /12 hour was administered before the procedure and continued for 5 days after the procedure At first the cyst morphology was evaluated by EUS and color Doppler ultrasound is used to identify nearby vessels The puncture was performed using a 19-gauge needle, which was introduced into the pseudocyst via a therapeutic linear array echoendoscope. Then, a 0.035-inch guidewire was introduced through the needle and coiled within the pseudocyst under fluoroscopic guidance.
The needle was removed and a 10F cystotome was advanced over the guidewire and the tract was dilated by the cystotome, after dilatation, a 10F double-pigtail stent was placed and a sample of the aspirate is sent for chemical and microbiological analysis
for pancreatic pseudocyst general anesthesia, 1 gm of cefotax was given IV at the induction of anaesthesia, supine position over the operating table A transverse supraumbilical incision was performed. A 5 cm horizontal anterior gastrotomy was performed (Image 23a). Hemostasis of the submucosal vessels was performed before the incision of the gastric mucosa.
First, the cyst was punctured followed by an incision of 5 cm at the posterior gastric wall. Aspiration of the cyst content was done for chemical and microbiological analysis The wall of the pseudocyst is hemmed to the gastric wall with continuous sutures made of a vicryl 2/0 alongside the entire circumference of the orifice Nasogastric tube was placed in the stomach. The procedure was completed by suturing the anterior gastrotomy with a vicryl 2/0 continous sutures in 2 layers A tube drain was inserted at the pelvis with closure of the abdominal wound in a standard way.
PCD
endoscopic approach it was done to one patient in the form of EUS guided aspiration of pus in a case with infected necrosis followed by percutaneous US guided aspiration of the residual
Time frame: immediately following intervention to 6 weeks following intervention
Data were tabulated and statistically analyzed in terms of percentages Success of the intervention means patient condition improves [clinical (vital signs) , laboratory (CBC, kidney and liver function tests) and radiological improvement (no residual collection in CT)] and that there is no need for further intervention to control the disease till patient discharge
Time frame: up to 6 months following intervention
Data were tabulated and statistically analyzed in terms of percentages
Time frame: from admission to 6 months following admission
Data were tabulated and statistically analyzed in terms of percentages
Time frame: up to 6 months
Data were tabulated and statistically analyzed in terms of frequencies length of hospital stay in days
Time frame: at admission
Data were tabulated and statistically analyzed in terms of mean
Time frame: at admission
Data were tabulated and statistically analyzed in terms of percentages
Zagazig University
Other Gov
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07712081
Acute Pancreatitis, Digestive System Diseases
Rui’an, Zhejiang, China
View Trial DetailsNCT05651360
Abdominal Pain, Acute Appendicitis
Odense, Denmark
View Trial DetailsNCT05201053
Acute Pancreatitis, Digestive System Diseases
Malmö, Skåne County, Sweden
View Trial DetailsNCT03401190
Acute Pancreatitis, Digestive System Diseases
Detroit, Michigan, United States
View Trial Details